Aug 8 (Reuters) - Paion AG PA8G.DE :
* REVENUES IN FIRST HALF-YEAR 2018 AMOUNTED TO EUR 0.5 MILLION COMPARED TO EUR 4.1 MILLION
YEAR
AGO
* RESEARCH AND DEVELOPMENT EXPENSES AMOUNTED TO EUR 6.5 MILLION IN FIRST HALF-YEAR 2018
* NET LOSS FOR FIRST HALF-YEAR 2018 AMOUNTED TO EUR 6.2 MILLION COMPARED TO A NET LOSS OF
EUR 5.8
MILLION YEAR AGO
* CASH AND CASH EQUIVALENTS DECREASED BY EUR 1.6 MILLION IN FIRST HALF-YEAR 2018
* EXPECTS REVENUES OF ABOUT EUR 3 MILLION IN 2018
* IN CASE OF REGULATORY FILING IN U.S. IN Q4 2018, REVENUES WOULD INCREASE BY EUR 7.5
MILLION IN
2018
* NET LOSS IS EXPECTED TO AMOUNT TO BETWEEN APPROX. EUR 12.5 MILLION AND APPROX. EUR 15
MILLION IN
2018
* TO REQUIRE ADDITIONAL FUNDS OF ABOUT EUR 10 MILLION UNTIL FILING FOR REGULATORY APPROVAL
OF
REMIMAZOLAM IN EU
Source text for Eikon: ID:nEQ75K2Yna
Further company coverage: PA8G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))